Evidence map›Paper›PMID 19484260›Full record

ArticleVirchows Archiv : an international journal of pathology2009

LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

E Long, M Ilie, V Hofman, K Havet, E Selva, C Butori, J P Lacour, A M Nelson, G Cathomas, P Hofman

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors.Frontiers in cell and developmental biology · 2025
    Review
  2. Review
  3. HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Review
  7. Pathology of infectious diseases: what does the future hold?Virchows Archiv : an international journal of pathology · 2017
    Review
  8. KSHV Genome Replication and Maintenance.Frontiers in microbiology · 2016
    Review
  9. Review
  10. Review
  11. Biomarkers of HIV-associated Cancer.Biomarkers in cancer · 2014
    Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

E LongLaboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, Nice 06002, France.
M Ilie
V Hofman
K Havet
E Selva
C Butori
J P Lacour
A M Nelson
G Cathomas
P Hofman
Hôpital Pasteur · FRInserm · FRArmed Forces Institute of Pathology · USUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human herpesvirus 8 (HHV8) is necessary for Kaposi sarcoma (KS) to develop, but whether the tissue viral load is a marker of KS progression is still unclear. Little is known about the level of expression of apoptosis-regulating proteins and of hypoxia-inducible factors (HIFs) in KS tumour cells relative to HHV8 expression. We therefore investigated the expression of the latency-associated nuclear antigen (LANA-1) of HHV8, Bcl-2, Mcl-1, Bax, Bcl-xL, caspase 3 and HIF-1alphain KS tissue specimens at different stages of the disease. The expression of these proteins was evaluated immunohistochemically using tissue microarrays (TMAs) in tissue specimens from 245 HIV-positive patients at different stages of the disease. Both LANA-1 and HIF-1alpha were expressed in KS biopsies taken at different stages, but their level increased throughout tumour progression. Additionally, the levels of Bcl-2 and Mcl-1 were higher in visceral KS lesions compared to levels observed in cutaneous and mucosal KS. This study demonstrates that late tumour stages of KS in tissues from HIV-positive patients are associated with high levels of LANA-1, HIF-1alpha and of the anti-apoptotic proteins, Bcl-2 and Mcl-1. Finally, the expression of these proteins can be potentially used as a tissue biomarker in defining patients with a higher risk of disease progression.

Indexed as

AdultAgedAntigens, ViralBiomarkers, TumorBiopsyDisease ProgressionFemaleGene Expression Regulation, NeoplasticHIV InfectionsHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiddle AgedMyeloid Cell Leukemia Sequence 1 ProteinNuclear ProteinsProto-Oncogene Proteins c-bcl-2Antigens, ViralBiomarkers, TumorHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunitlatency-associated nuclear antigenMyeloid Cell Leukemia Sequence 1 ProteinNuclear ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19484260
OpenAlexW2090277399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.